ATE491471T1 - Adjuvantien für dns impstoffe basierend auf imidazochinoline - Google Patents

Adjuvantien für dns impstoffe basierend auf imidazochinoline

Info

Publication number
ATE491471T1
ATE491471T1 AT03712390T AT03712390T ATE491471T1 AT E491471 T1 ATE491471 T1 AT E491471T1 AT 03712390 T AT03712390 T AT 03712390T AT 03712390 T AT03712390 T AT 03712390T AT E491471 T1 ATE491471 T1 AT E491471T1
Authority
AT
Austria
Prior art keywords
adjuvants
imidazocinoline
dna vaccines
vaccines based
relates
Prior art date
Application number
AT03712390T
Other languages
English (en)
Inventor
Ralph Braun
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/102,615 external-priority patent/US20030185835A1/en
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Application granted granted Critical
Publication of ATE491471T1 publication Critical patent/ATE491471T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03712390T 2002-03-19 2003-03-19 Adjuvantien für dns impstoffe basierend auf imidazochinoline ATE491471T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36605702P 2002-03-19 2002-03-19
US10/102,615 US20030185835A1 (en) 2002-03-19 2002-03-19 Adjuvant for vaccines
PCT/GB2003/001203 WO2003080114A2 (en) 2002-03-19 2003-03-19 Imidazoquinoline adjuvants for vaccines

Publications (1)

Publication Number Publication Date
ATE491471T1 true ATE491471T1 (de) 2011-01-15

Family

ID=28456582

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03712390T ATE491471T1 (de) 2002-03-19 2003-03-19 Adjuvantien für dns impstoffe basierend auf imidazochinoline

Country Status (10)

Country Link
US (1) US20060088542A1 (de)
EP (1) EP1487485B1 (de)
JP (1) JP2005526793A (de)
AT (1) ATE491471T1 (de)
AU (1) AU2003216851B2 (de)
CA (1) CA2484049A1 (de)
DE (1) DE60335350D1 (de)
DK (1) DK1487485T3 (de)
PT (1) PT1487485E (de)
WO (1) WO2003080114A2 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1590348A1 (de) 2002-12-20 2005-11-02 3M Innovative Properties Company Aryl / hetaryl-substituierte imidazochinoline
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
US7176214B2 (en) 2003-05-21 2007-02-13 Bristol-Myers Squibb Company Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
AU2004266162A1 (en) * 2003-08-25 2005-03-03 3M Innovative Properties Company Immunostimulatory combinations and treatments
NZ545412A (en) * 2003-08-27 2008-12-24 Coley Pharm Group Inc Aryloxy and arylalkyleneoxy substituted imidazoquinolines
KR101494056B1 (ko) 2003-10-03 2015-02-16 쓰리엠 이노베이티브 프로퍼티즈 컴파니 피라졸로피리딘 및 그의 유사체
EP1673087B1 (de) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy-substituierte imidazochinoline
SG146662A1 (en) * 2003-10-10 2008-10-30 Powderject Vaccines Inc Method
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
WO2006009826A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US8541438B2 (en) 2004-06-18 2013-09-24 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
DE102004049223A1 (de) * 2004-10-08 2006-04-20 Johannes-Gutenberg-Universität Mainz Zubereitung zum Impfen, Impfverfahren und Verwendung einer Impf-Zubereitung
CA2592904C (en) 2004-12-30 2015-04-07 3M Innovative Properties Company Chiral fused [1,2]imidazo[4,5-c] ring compounds
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
US20080318998A1 (en) 2005-02-09 2008-12-25 Coley Pharmaceutical Group, Inc. Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines
CA2602083A1 (en) 2005-02-09 2006-08-09 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted thiazolo(4,5-c) ring compounds and methods
CA2597446A1 (en) * 2005-02-11 2006-08-31 Coley Pharmaceutical Group, Inc. Substituted imidazoquinolines and imidazonaphthyridines
AU2006216686A1 (en) * 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Method of preferentially inducing the biosynthesis of interferon
EP1851218A2 (de) * 2005-02-23 2007-11-07 3M Innovative Properties Company Hydroxyalkylsubstituierte imidazochinolinverbindungen und verfahren
CA2598639A1 (en) 2005-02-23 2006-08-31 Coley Pharmaceutical Group, Inc. Hydroxyalkyl substituted imidazonaphthyridines
AU2006223634A1 (en) * 2005-02-23 2006-09-21 Coley Pharmaceutical Group, Inc. Hydroxyalkyl substituted imidazoquinolines
AU2006287270A1 (en) * 2005-09-09 2007-03-15 Coley Pharmaceutical Group, Inc. Amide and carbamate derivatives of N-{2-[4-amino-2- (ethoxymethyl)-1H-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
ZA200803029B (en) 2005-09-09 2009-02-25 Coley Pharm Group Inc Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
WO2007056112A2 (en) 2005-11-04 2007-05-18 Coley Pharmaceutical Group, Inc. Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
NZ567979A (en) * 2005-11-04 2012-02-24 Novartis Vaccines & Diagnostic Adjuvanted influenza vaccines including a cytokine-inducing agents which is an agonist of Toll-Like Receptor 7
EP1988896A4 (de) 2006-02-22 2011-07-27 3M Innovative Properties Co Konjugate zur modifizierung von immunreaktionen
WO2007106854A2 (en) * 2006-03-15 2007-09-20 Coley Pharmaceutical Group, Inc. Hydroxy and alkoxy substituted 1h-imidazonaphthyridines and methods
BRPI0713711A2 (pt) * 2006-06-20 2012-10-30 Transgene Sa vacina viral recombinante, kit para vacinação, e, método para usar pelo menos um composto
WO2008010963A2 (en) * 2006-07-18 2008-01-24 3M Innovative Properties Company Immune response modifier formulations
US8178539B2 (en) * 2006-09-06 2012-05-15 3M Innovative Properties Company Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
EP2244695A1 (de) * 2007-12-07 2010-11-03 Novartis AG Zusammensetzungen zur induktion von immunantworten
EP2286824B1 (de) * 2008-05-07 2013-08-14 Osaka University Nicht-kovalentes vernetzungsmittel für kollagen
MX2011007559A (es) * 2009-01-20 2011-12-06 Myelin Repair Foundation Inc Composiciones y metodos para induccion de tolerancia antigeno-especifica.
LT2606047T (lt) 2010-08-17 2017-04-10 3M Innovative Properties Company Imuninio atsako modifikatoriaus junginio lipidizuotos kompozicijos, sudėtys ir būdai
JP5909745B2 (ja) 2010-11-12 2016-04-27 クール ファーマシューティカルズ ディベロップメント カンパニー 炎症性疾患の治療薬、ならびにウイルスまたは細菌感染疾患の治療薬
EP2717919B1 (de) 2011-06-03 2016-08-03 3M Innovative Properties Company Heterobifunktionale linker mit polyethylenglykolsegmenten und daraus hergestellte immunantwort-modifizierende konjugate
CA2838023C (en) 2011-06-03 2019-08-13 3M Innovative Properties Company Hydrazino 1h-imidazoquinolin-4-amines and conjugates made therefrom
CA2876495C (en) 2012-06-21 2023-10-17 Northwestern University Peptide conjugated particles
HK1220368A1 (zh) 2013-03-13 2017-05-05 Cour Pharmaceuticals Development Company 用於治疗炎症的免疫修饰性颗粒
CN105555301B (zh) 2013-08-13 2021-04-16 西北大学 肽缀合颗粒
US9884866B2 (en) 2014-09-08 2018-02-06 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
SG11201802769RA (en) 2015-10-29 2018-05-30 Novartis Ag Antibody conjugates comprising toll-like receptor agonist
US10730871B2 (en) 2016-01-28 2020-08-04 Regents Of The University Of Minnesota Immunomodulators and immunomodulator conjugates
EP3728255B1 (de) 2017-12-20 2022-01-26 3M Innovative Properties Company Amid-substituierte imidazo[4,5-c]chinolin-verbindungen mit verzweigtkettenverbindungsgruppe zur verwendung als immunreaktionsmodifikator
US12060350B2 (en) 2018-07-02 2024-08-13 Regents Of The University Of Minnesota Therapeutic compounds and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US5238944A (en) * 1988-12-15 1993-08-24 Riker Laboratories, Inc. Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
US5389640A (en) * 1991-03-01 1995-02-14 Minnesota Mining And Manufacturing Company 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5352784A (en) * 1993-07-15 1994-10-04 Minnesota Mining And Manufacturing Company Fused cycloalkylimidazopyridines
KR100341341B1 (ko) * 1993-07-15 2002-11-25 미네소타 마이닝 앤드 매뉴팩춰링 캄파니 이미다조[4,5-c]피리딘-4-아민
US5482936A (en) * 1995-01-12 1996-01-09 Minnesota Mining And Manufacturing Company Imidazo[4,5-C]quinoline amines
US20010006950A1 (en) * 1998-02-11 2001-07-05 Juha Punnonen Genetic vaccine vector engineering
US6110929A (en) * 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
EP1005170B1 (de) * 1998-11-27 2002-02-13 STMicroelectronics S.r.l. Flash Analog-Digitalwandler
NZ512628A (en) * 1999-01-08 2004-03-26 3M Innovative Properties Co Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
US6558951B1 (en) * 1999-02-11 2003-05-06 3M Innovative Properties Company Maturation of dendritic cells with immune response modifying compounds
US6331539B1 (en) * 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
GB0023008D0 (en) * 2000-09-20 2000-11-01 Glaxo Group Ltd Improvements in vaccination
US20030190308A1 (en) * 2002-03-19 2003-10-09 Braun Ralph P. Adjuvant
JP2005533752A (ja) * 2002-03-19 2005-11-10 パウダーメド リミテッド Ｈｉｖｄｎａワクチン接種におけるアジュバントとしてのイミダゾキノリンアミン
GB0206461D0 (en) * 2002-03-19 2002-05-01 Glaxo Group Ltd Improvements in vaccination

Also Published As

Publication number Publication date
WO2003080114A2 (en) 2003-10-02
AU2003216851B2 (en) 2008-04-17
JP2005526793A (ja) 2005-09-08
AU2003216851A1 (en) 2003-10-08
CA2484049A1 (en) 2003-10-02
DE60335350D1 (de) 2011-01-27
PT1487485E (pt) 2011-03-11
WO2003080114A3 (en) 2003-11-06
DK1487485T3 (da) 2011-03-14
US20060088542A1 (en) 2006-04-27
EP1487485B1 (de) 2010-12-15
EP1487485A2 (de) 2004-12-22

Similar Documents

Publication Publication Date Title
DE60335350D1 (de) Adjuvantien für dns impstoffe basierend auf imidazochinoline
BR0313414A (pt) ácidos nucléicos imunoestimulatórios
ATE426412T1 (de) Adjuvante influenza-vakzine
NO20070263L (no) Immunostimulerende oligonukleotidmultimerer
CY1112490T1 (el) Σταθεροποιητες για εμβολια ξηρανθεντα δια καταψυξεως
DE60228758D1 (de) Immunisierung gegen chlamydia tracheomatis
CY1107390T1 (el) Εμβολιο εναντι αντιγονων απο βακτηριδια
MXPA05009580A (es) Vacuna contra el virus de la influenza.
SG145767A1 (en) Improvements in vaccination
CY1112749T1 (el) Εμβολια διεγερσης/αναμνησης κατα της ελονοσιας
EA200501890A1 (ru) Вирусы гриппа высокого титра для приготовления вакцин и генной терапии
WO2007075626A3 (en) Immunostimulatory activity of palindromic immune modulatory oligonucleotides (imo tm) contiaining different lengths of palindromic segments
ATE463575T1 (de) Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
BRPI0508064A (pt) flavivìrus, composição de vacina e molécula de ácido nucléico
DE60037900D1 (de) Chlamydia antigene und entsprechende dna-fragmente und ihre verwendungen
ATE392216T1 (de) Mycobakterieller impfstoff
ATE521621T1 (de) Cpg-einzelstrang-desoxynukleotide zur verwendung als adjuvans
CY1107845T1 (el) Γενετικα εμβολια με ανοσοενισχυτικο
DK1664100T3 (da) Vaccine med underenhed af Lawsonia intracellularis
DE60139959D1 (de) Nukleinsäureadjuvantien
EP1667634A4 (de) Anthrax-vakzine
DE60229966D1 (de) Diabetesmodell
TNSN05052A1 (en) Immunostimulatory nucleic acids
WO2003031470A3 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose
BRPI0604365A (pt) polipeptìdeo isolado, composição de vacina anti-carrapato de múltiplas espécies, e, uso dos mesmos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1487485

Country of ref document: EP